Respiratory Insufficiency Clinical Trial
— HILOOPOfficial title:
Safety and Efficacy of a Closed-loop Oxygen Control for High Flow Nasal Therapy in ICU Patients: a Randomized Cross-over Study (The HILOOP Study)
Verified date | October 2021 |
Source | Hospital Universitari Vall d'Hebron Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In patients with acute hypoxemic respiratory failure (AHRF), High Flow Nasal Therapy (HFNT) improves oxygenation, tolerance, and decrease work of breathing as compared to standard oxygen therapy by facemask. Current guidelines recommend adjusting oxygen flow rates to keep the oxygen saturation measured by pulse oximetry (SpO2) in the target range and avoid hypoxemia and hyperoxemia. The hypothesis of the study is that closed loop oxygen control increases the time spent within clinically targeted SpO2 ranges and decreases the time spent outside clinical target SpO2 ranges as compared to manual oxygen control in ICU patients treated with HFNT.
Status | Completed |
Enrollment | 53 |
Est. completion date | August 10, 2021 |
Est. primary completion date | August 10, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Adult (>17yo) patients admitted to the ICU treated with HFNT for at least 8h - Requiring FiO2 = 30% to keep SpO2 in the target ranges defined by the clinician - Written informed consent signed and dated by the patient or one relative in case that the patient is unable to consent, after full explanation of the study by the investigator and prior to study participation. Exclusion Criteria: - Patient with indication for immediate continuous positive airway pressure (CPAP), noninvasive ventilation (NIV), or invasive mechanical ventilation - Hemodynamic instability defined as a need of continuous infusion of epinephrine or norepinephrine > 1 mg/h - Low quality on the SpO2 measurement using finger and ear sensor (quality index below 60% on the Massimo SpO2 sensor, which is displayed by a red or orange colour bar) - Severe acidosis (pH = 7.30) - Pregnant woman - Patients deemed at high risk for need of mechanical ventilation within the next 8 hours - Chronic or acute dyshemoglobinemia: methemoglobin, carbon monoxide (CO) poisoning, sickle cell disease - Tracheotomised patient - Formalized ethical decision to withhold or withdraw life support - Patient under guardianship - Patient deprived of liberties - Patient included in another interventional research study under consent - Patient already enrolled in the present study in a previous episode of acute respiratory failure |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital Universitari Vall d'Hebron | Barcelona |
Lead Sponsor | Collaborator |
---|---|
Hospital Universitari Vall d'Hebron Research Institute |
Spain,
Arnal JM, Garnero A, Novotni D, Corno G, Donati SY, Demory D, Quintana G, Ducros L, Laubscher T, Durand-Gasselin J. Closed loop ventilation mode in Intensive Care Unit: a randomized controlled clinical trial comparing the numbers of manual ventilator setting changes. Minerva Anestesiol. 2018 Jan;84(1):58-67. doi: 10.23736/S0375-9393.17.11963-2. Epub 2017 Jul 5. — View Citation
Helmerhorst HJ, Roos-Blom MJ, van Westerloo DJ, de Jonge E. Association Between Arterial Hyperoxia and Outcome in Subsets of Critical Illness: A Systematic Review, Meta-Analysis, and Meta-Regression of Cohort Studies. Crit Care Med. 2015 Jul;43(7):1508-19. doi: 10.1097/CCM.0000000000000998. Review. — View Citation
L'Her E, Dias P, Gouillou M, Riou A, Souquiere L, Paleiron N, Archambault P, Bouchard PA, Lellouche F. Automatic versus manual oxygen administration in the emergency department. Eur Respir J. 2017 Jul 20;50(1). pii: 1602552. doi: 10.1183/13993003.02552-2016. Print 2017 Jul. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of time spent in optimal SpO2 range | The optimal SpO2 range will be defined according to the SpO2 targets determined by the clinician. | 4 hours | |
Secondary | Percentage of time spent in sub-optimal SpO2 range | SpO2 values outside the optimal range but still within an acceptable limit (2-3 percent above and below the optimal range) | 4 hours | |
Secondary | Percentage of time spent out of range | Above or below the suboptimal limits specified at the begginning of the study | 4 hours | |
Secondary | Percentage of time with SpO2 signal available | Time with SpO2 signal available | 4 hours | |
Secondary | Mean SpO2/FiO2 | Mean oxygenation value | 4 hours | |
Secondary | ROX index | Is a predictor of HFNT success/failure defined as (SpO2/FiO2)/respiratory rate | 4 hours | |
Secondary | Percentage of time with SpO2 below 88 and 85 percent | Duration of time with SpO2 <85 percent and <88 percent, respectively | 4 hours | |
Secondary | Number of events with SpO2 below 88 and 85 percent | Frequency of SpO2 decreases <85 percent and <88 percent, respectively | 4 hours | |
Secondary | Mean FiO2 | Mean fraction of inspired oxygen | 4 hours | |
Secondary | Percentage of time with FiO2 below 40 percent and above 60% | Percentage of time that FiO2 is <40 percent and >60 percent, respectively | 4 hours | |
Secondary | Number of manual adjustments | Frequency of manual adjustments of FiO2 | 4 hours | |
Secondary | Number of alarms | Frequency of alarms | 4 hours | |
Secondary | Patient comfort | Comfort score by visual analogic scale (from 0 to 10) | 4 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05904652 -
High Flow Nasal Oxygen at Extubation for Adults Requiring a Breathing Tube for Treating Severe Breathing Difficulties
|
N/A | |
Completed |
NCT04030208 -
Evaluating Safety and Efficacy of Umbulizer in Patients Requiring Intermittent Positive Pressure Ventilation
|
N/A | |
Recruiting |
NCT03697785 -
Weaning Algorithm for Mechanical VEntilation
|
N/A | |
Recruiting |
NCT02989051 -
Fluid Restriction Keeps Children Dry
|
Phase 2/Phase 3 | |
Completed |
NCT02930525 -
Effect of High Flow Nasal Cannula vs. Standard Care on Respiratory Stability in Pediatric Procedural Sedation
|
N/A | |
Recruiting |
NCT02539732 -
Prediction of Outcome of Weaning From Mechanical Ventilation Using the Electrical Activity of the Diaphragm
|
||
Enrolling by invitation |
NCT02290236 -
Monitored Saturation Post-ICU
|
N/A | |
Completed |
NCT02056119 -
RCT of Mesh Versus Jet Nebulizers on Clinical Outcomes During Mechanical Ventilation in the Intensive Care Unit
|
N/A | |
Terminated |
NCT01583088 -
Early Stage Amyotrophic Lateral Sclerosis Phrenic Stimulation
|
Phase 3 | |
Withdrawn |
NCT00990119 -
High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD)
|
N/A | |
Completed |
NCT00741949 -
Broncho-alveolar Lavage Under Noninvasive Ventilation With Propofol TCI in Patient With AHRF
|
Phase 3 | |
Completed |
NCT01411722 -
Electrical Activity of the Diaphragm During the Weaning Period
|
Phase 2 | |
Recruiting |
NCT00339053 -
Immunonutrition and Thoracoabdominal Aorta Aneurysm Repair
|
Phase 4 | |
Recruiting |
NCT00187434 -
Comparison of Two Methods of Continuous Positive Airway Pressure (CPAP) to Support Successful Extubation of Infants of Birth Weights ≤ 1500 Grams (C2CPAP)
|
N/A | |
Completed |
NCT02687802 -
Respiratory Mechanics and Patient-ventilator Asynchrony Index in Patients With Invasive Mechanical Ventilation
|
||
Not yet recruiting |
NCT05906030 -
Diaphragm Dysfunction and Ultrasound Perioperatively
|
||
Completed |
NCT03850977 -
Is There an Association Between Chronic Pancreatitis and Pulmonary Function
|
||
Completed |
NCT02845375 -
Effect of Neuromuscular Blockade and Reversal on Breathing
|
Phase 4 | |
Recruiting |
NCT03309423 -
Is Venous to Arterial Conversion (v-TAC) of Blood Gas Reliable in Critical Ill Patients in the ICU?
|
N/A | |
Completed |
NCT04115969 -
Outcome After Non-invasive Ventilation.
|